Merck KGaA Chief Executive Stefan Oschmann put the Germany company’s consumer-health unit on the block in a move that will focus its health-care activities on the riskier business of developing prescription medicines.
from WSJ.com: US Business http://ift.tt/2wDTvce
via IFTTT
No comments:
Post a Comment